Please Wait

Applying Filters...

Veranova A CDMO that manages complexity with confidence

Veranova A CDMO that manages complexity with confidence

X

Looking for Poly L Lactide? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

Filters

FILTER :

filter Company

All (2)

01 Nomisma Healthcare (2)

filter Country

All (2)

01 India (2)

price-trend

Nomisma Healthcare

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

PLLA-PEG

PDF Supplier PDF

URL Supplier Web Content

LM Application #LearnMore

Applications:

PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly L Lactide

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral

Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades

CPHI India 2023

Attending

envelop Contact Supplier

Nomisma Healthcare

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

PLLA

PDF Supplier PDF

URL Supplier Web Content

LM Application #LearnMore

Applications:

PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

Ingredient(s): Poly L Lactide

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral

Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

CPHI India 2023

Attending

envelop Contact Supplier

POST ENQUIRY